371 related articles for article (PubMed ID: 17275196)
21. Accumulation of phosphorylated alpha-synuclein in dopaminergic neurons of transgenic mice that express human alpha-synuclein.
Wakamatsu M; Ishii A; Ukai Y; Sakagami J; Iwata S; Ono M; Matsumoto K; Nakamura A; Tada N; Kobayashi K; Iwatsubo T; Yoshimoto M
J Neurosci Res; 2007 Jun; 85(8):1819-25. PubMed ID: 17465029
[TBL] [Abstract][Full Text] [Related]
22. Determining nuclear localization of alpha-synuclein in mouse brains.
Huang Z; Xu Z; Wu Y; Zhou Y
Neuroscience; 2011 Dec; 199():318-32. PubMed ID: 22033456
[TBL] [Abstract][Full Text] [Related]
23. The ultrastructural distribution of alpha-synuclein-like protein in normal mouse brain.
Totterdell S; Hanger D; Meredith GE
Brain Res; 2004 Apr; 1004(1-2):61-72. PubMed ID: 15033420
[TBL] [Abstract][Full Text] [Related]
24. An antibody with high reactivity for disease-associated α-synuclein reveals extensive brain pathology.
Kovacs GG; Wagner U; Dumont B; Pikkarainen M; Osman AA; Streichenberger N; Leisser I; Verchère J; Baron T; Alafuzoff I; Budka H; Perret-Liaudet A; Lachmann I
Acta Neuropathol; 2012 Jul; 124(1):37-50. PubMed ID: 22370907
[TBL] [Abstract][Full Text] [Related]
25. alpha-Synuclein is differentially expressed in mitochondria from different rat brain regions and dose-dependently down-regulates complex I activity.
Liu G; Zhang C; Yin J; Li X; Cheng F; Li Y; Yang H; Uéda K; Chan P; Yu S
Neurosci Lett; 2009 May; 454(3):187-92. PubMed ID: 19429081
[TBL] [Abstract][Full Text] [Related]
26. Mapping of rat brain using the Synuclein-1 monoclonal antibody reveals somatodendritic expression of alpha-synuclein in populations of neurons homologous to those vulnerable to Lewy body formation in human synucleopathies.
Andringa G; Du F; Chase TN; Bennett MC
J Neuropathol Exp Neurol; 2003 Oct; 62(10):1060-75. PubMed ID: 14575241
[TBL] [Abstract][Full Text] [Related]
27. Localization of the GoLoco motif carrier regulator of G-protein signalling 12 and 14 proteins in monkey and rat brain.
López-Aranda MF; Acevedo MJ; Carballo FJ; Gutiérrez A; Khan ZU
Eur J Neurosci; 2006 Jun; 23(11):2971-82. PubMed ID: 16819986
[TBL] [Abstract][Full Text] [Related]
28. Prominent perikaryal expression of alpha- and beta-synuclein in neurons of dorsal root ganglion and in medullary neurons.
Giasson BI; Duda JE; Forman MS; Lee VM; Trojanowski JQ
Exp Neurol; 2001 Dec; 172(2):354-62. PubMed ID: 11716559
[TBL] [Abstract][Full Text] [Related]
29. Immunohistochemical distribution and subcellular localization of three distinct specific molecular structures of advanced glycation end products in human tissues.
Ling X; Sakashita N; Takeya M; Nagai R; Horiuchi S; Takahashi K
Lab Invest; 1998 Dec; 78(12):1591-606. PubMed ID: 9881959
[TBL] [Abstract][Full Text] [Related]
30. Cytoplasmic CREB alpha-like antigens in specific regions of the rat brain.
Hermanson O; Gustavsson J; Strålfors P; Blomqvist A
Biochem Biophys Res Commun; 1996 Aug; 225(1):256-62. PubMed ID: 8769127
[TBL] [Abstract][Full Text] [Related]
31. Characterization and localization of the BM88 antigen in the developing and adult rat brain.
Patsavoudi E; Merkouri E; Thomaidou D; Sandillon F; Alonso G; Matsas R
J Neurosci Res; 1995 Mar; 40(4):506-18. PubMed ID: 7616611
[TBL] [Abstract][Full Text] [Related]
32. Localization of alpha-synuclein to identified fibers and synapses in the normal mouse brain.
Totterdell S; Meredith GE
Neuroscience; 2005; 135(3):907-13. PubMed ID: 16112475
[TBL] [Abstract][Full Text] [Related]
33. Alpha-synuclein acts in the nucleus to inhibit histone acetylation and promote neurotoxicity.
Kontopoulos E; Parvin JD; Feany MB
Hum Mol Genet; 2006 Oct; 15(20):3012-23. PubMed ID: 16959795
[TBL] [Abstract][Full Text] [Related]
34. Characterization of neuropeptide Y2 receptor protein expression in the mouse brain. I. Distribution in cell bodies and nerve terminals.
Stanić D; Brumovsky P; Fetissov S; Shuster S; Herzog H; Hökfelt T
J Comp Neurol; 2006 Nov; 499(3):357-90. PubMed ID: 16998904
[TBL] [Abstract][Full Text] [Related]
35. Melatonin reduces the expression of alpha-synuclein in the dopamine containing neuronal regions of amphetamine-treated postnatal rats.
Sae-Ung K; Uéda K; Govitrapong P; Phansuwan-Pujito P
J Pineal Res; 2012 Jan; 52(1):128-37. PubMed ID: 21851386
[TBL] [Abstract][Full Text] [Related]
36. Conformational properties of the SDS-bound state of alpha-synuclein probed by limited proteolysis: unexpected rigidity of the acidic C-terminal tail.
de Laureto PP; Tosatto L; Frare E; Marin O; Uversky VN; Fontana A
Biochemistry; 2006 Sep; 45(38):11523-31. PubMed ID: 16981712
[TBL] [Abstract][Full Text] [Related]
37. Phosphorylation-dependent dimerization and subcellular localization of islet-brain 1/c-Jun N-terminal kinase-interacting protein 1.
Borsello T; Centeno C; Riederer IM; Haefliger JA; Riederer BM
J Neurosci Res; 2007 Dec; 85(16):3632-41. PubMed ID: 17663463
[TBL] [Abstract][Full Text] [Related]
38. Alterations in lysosomal and proteasomal markers in Parkinson's disease: relationship to alpha-synuclein inclusions.
Chu Y; Dodiya H; Aebischer P; Olanow CW; Kordower JH
Neurobiol Dis; 2009 Sep; 35(3):385-98. PubMed ID: 19505575
[TBL] [Abstract][Full Text] [Related]
39. Widespread immunoreactivity for neuronal nuclei in cultured human and rodent astrocytes.
Darlington PJ; Goldman JS; Cui QL; Antel JP; Kennedy TE
J Neurochem; 2008 Mar; 104(5):1201-9. PubMed ID: 17995928
[TBL] [Abstract][Full Text] [Related]
40. Monoclonal antibodies recognizing epitopes of calretinins: dependence on Ca2+-binding status and differences in antigen accessibility in colon cancer cells.
Zimmermann L; Schwaller B
Cell Calcium; 2002 Jan; 31(1):13-25. PubMed ID: 11990296
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
